Impact of Home Medicines Review on medication regimen complexity

被引:0
作者
Seth, Shrey [1 ,2 ]
Lukose, Lipin [1 ,2 ]
Tesfaye, Wubshet H. [2 ]
Sridhar, Sathvik B. [3 ]
Thunga, Girish [1 ]
Castelino, Ronald L. [2 ,4 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharm Practice, Manipal, India
[2] Univ Sydney, Fac Med & Hlth, Sydney Sch Pharm, Sydney, Australia
[3] RAK Med & Hlth Sci Univ, RAK Coll Pharm, Dept Clin Pharm & Pharmacol, Ras Al Khaymah, U Arab Emirates
[4] Blacktown Hosp, Pharm Dept, Blacktown, Australia
关键词
home medicines reviews; Medication Regimen Complexity Index; pharmacy services; complex medication regimens; DRUG-RELATED PROBLEMS; VALIDATION; INDEX;
D O I
10.1002/jppr.1945
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundPrevious studies on pharmacist-led Home Medicines Review (HMR) have demonstrated positive associations of HMR and clinical outcomes. However, little is known about their impact on medication regimen complexity.AimInvestigate the impact of pharmacist-led HMRs on simplifying medication regimen complexity using the Medication Regimen Complexity Index (MRCI).MethodA retrospective cohort study of 196 general practitioners (GPs) initiated HMRs, conducted over a period of 2 years (2020-2022) using two credentialed pharmacists in New South Wales, Australia. MRCI was used to measure the complexity at two separate time points, at baseline and following pharmacists' recommendations (assuming the GPs accepted all of the pharmacists' recommendations provided during the HMRs). The Wilcoxon signed-rank test was used to determine the difference between the scores at baseline and after HMR. Ethical approval was granted by the University of Sydney Human Research Ethics Committee (Reference no: 2022/584) and the study conforms to the Australian National statement on the ethical conduct in human research.ResultsDuring the HMR service, pharmacists made a total of 792 recommendations (mean +/- standard deviation [4.04 +/- 2.3] per HMR), among which dosage and frequency adjustment, laboratory monitoring, and therapeutic monitoring were the most common, collectively accounting for almost half of the recommendations. The median MRCI score at baseline was 28.5 (interquartile range [IQR] 21.5-37.6) and following pharmacists' recommendations was 29 (IQR 21.9-37.1). The difference between the baseline and post-HMR scores was not statistically significant.ConclusionOur study demonstrates the lack of significant reductions in medication complexity following HMRs as measured by the MRCI. However, these results need to be interpreted with caution as not all interactions with patients lead to a change in the MRCI score. Comprehensive examination of individual medication changes may provide more meaningful and clinically relevant inferences.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis
    Spargo, Maureen
    Ryan, Cristin
    Downey, Damian
    Hughes, Carmel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (05) : 1342 - 1348
  • [22] Home medicines reviews and residential medication management reviews in Western Australia
    Czarniak, Petra
    Hattingh, Laetitia
    Si, Tin Fei
    Parsons, Richard
    Wright, Bronwen
    Sunderland, Bruce
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) : 567 - 578
  • [23] Are Clinical Outcomes Associated With Medication Regimen Complexity? A Systematic Review and Meta-analysis
    Alves-Conceicao, Vanessa
    Santos Rocha, Kerilin Stancine
    Nascimento Silva, Fernanda Vilanova
    Santos Silva, Rafaella de Oliveira
    Cerqueira-Santos, Sabrina
    Prado Nunes, Marco Antonio
    Saquete Martins-Filho, Paulo Ricardo
    da Silva, Daniel Tenorio
    de Lyra, Divaldo Pereira, Jr.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (04) : 301 - 313
  • [24] Medication regimen complexity of coronary artery disease patients
    Tinoco, Marlon Silva
    de Souza Groia-Veloso, Ronara Camila
    Domingos dos Santos, Jessica Nathalia
    Martins Cruzeiro, Maria Gabriela
    Dias, Bianca Menezes
    Moreira Reis, Adriano Max
    EINSTEIN-SAO PAULO, 2021, 19 : eAO5565
  • [25] Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes
    Rettig, Stephen M.
    Wood, Yelena
    Hirsch, Jan D.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (04) : 427 - 431
  • [26] Correlation between medication regimen complexity and quality of life in patients with heart failure
    Wilkening, G. Lucy
    Brune, Sonja
    Saenz, Pablo F.
    Vega, Lourdes M.
    Kalich, Bethany A.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (10) : 1498 - 1501
  • [27] The Impact of Medication Regimen Complexity on Patient-Related and Clinical Outcomes in Patients Undergoing Hemodialysis
    Goh, Jing Xin
    Tesfaye, Wubshet
    Van, Connie
    Sud, Kamal
    Seth, Shrey
    Tarafdar, Surjit
    Castelino, Ronald L.
    HEMODIALYSIS INTERNATIONAL, 2025, : 231 - 236
  • [28] Polypathology, polypharmacy, medication regimen complexity and drug therapy appropriateness
    Gomez Aguirre, N.
    Caudevilla Martinez, A.
    Bellostas Munoz, L.
    Crespo Avellana, M.
    Velilla Marco, J.
    Diez-Manglano, J.
    REVISTA CLINICA ESPANOLA, 2017, 217 (05): : 289 - 295
  • [29] Medication regimen complexity in ambulatory older adults with heart failure
    Cobretti, Michael R.
    Page, Robert L., II
    Linnebur, Sunny A.
    Deininger, Kimberly M.
    Ambardekar, Amrut V.
    Lindenfeld, JoAnn
    Aquilante, Christina L.
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 679 - 686
  • [30] Medication Regimen Complexity and Hospital Readmission for an Adverse Drug Event
    Willson, Megan N.
    Greer, Christopher L.
    Weeks, Douglas L.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (01) : 26 - 32